How has BioLife Solutions's gain on sale of business and assets changed year-over-year?

BioLife Solutions's gain on sale of business and assets decreased by 35.0% year-over-year, from $3.97M to $2.58M.

BioLife Solutions BLFS Gain on sale of business and assets

Gain on sale of business and assets at other companies

EcolabECL

-$1.1M-101%

RevvityRVTY

——

Charles River LaboratoriesCRL

——

International Flavors & FragrancesIFF

——

Standex InternationalSXI

——

Other financials

Income statement

See full

Revenue$27.5M+24.7%

Gross profit$17.5M+18.2%

Operating income$27.0K+105%

Net income$1.2M+365%

EPS (diluted)$0.02—

Balance sheet

See full

Cash & equivalents$22.8M-65.9%

Total debt$17.4M-35.6%

Total equity$372.2M+5.6%

Total assets$400.9M+1.5%

Cash flow

See full

Operating cash flow-$491.0K-128%

CapEx$167.0K-4.6%

Free cash flow-$658.0K-142%

Valuation

See full

Market cap$1.34B+33.1%

Enterprise value$1.34B+38.1%

P/S13.5×+0.6×

Profitability

See full

Gross margin66.9%—

Operating margin-16.7%—

Net margin-68.7%—

FCF margin-15.9%+18.7pp

Returns & leverage

See full

Return on equity-14.5%-4.7pp

Debt / equity0×0.0×

Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfBusiness.

The official record: BioLife Solutions’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's gain on sale of business and assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioLife Solutions's gain on sale of business and assets?: BioLife Solutions (BLFS) reported gain on sale of business and assets of $2.58M in Q4 2025.
How has BioLife Solutions's gain on sale of business and assets changed year-over-year?: BioLife Solutions's gain on sale of business and assets decreased by 35.0% year-over-year, from $3.97M to $2.58M.